MEDP - メッドペ―ス・ホ―ルディングス (Medpace Holdings Inc.) メッドペ―ス・ホ―ルディングス

 MEDPのチャート


 MEDPの企業情報

symbol MEDP
会社名 Medpace Holdings Inc (メッドペ―ス・ホ―ルディングス)
分野(sector) Health Care   ヘルスケア
産業(industry) Biotechnology: Commercial Physical_Biological Resarch  
業種 バイオテクノロジ―_メディカルリサ―チ   IT・通信(IT_Communications)
概要 事業概要 メッドペース・ホールディングス(Medpace Holdings Inc.)は臨床契約研究機関である。同社は臨床研究に基づく医薬品及び医療機器開発サービスを提供する。同社は医薬品、バイオ技術、および医療機器企業と協力して、臨床試験の開発・実施を行う。同社の麻薬開発サービスは、フルサービス第I-IV臨床開発サービスを主として、開発計画の設計、コーディネートされた中央検査室、プロジェクト管理、規制業務、臨床モニタリング、データ管理および分析、薬物動態検査の新薬申請の提出、および販売後のマーケティング臨床サポートを含む。また、バイオアナリティカルラボサービス、臨床ヒト薬理学、イメージングサービス、および臨床試験のための心電図読み取りのサポートを提供する。同社の事業は、主に北米、欧州、アジアに拠点を置く。   メッドペ―ス・ホ―ルディングスは米国の臨床試験受託企業。持株会社体制で、子会社を通じ臨床試験サ―ビスをバイオ医薬品企業や医療器具メ―カ―などの医療業界全体に提供する。主に心臓病、代謝性疾患、がん、内分泌系疾患、神経系疾患などに対する臨床試験をフェ―ズ1からフェ―ズ4まで実施する。本社はオハイオ州シンシナティ。   
本社所在地 5375 Medpace Way Cincinnati OH 45227 USA
代表者氏名 August J. Troendle 8月J.Troendle
代表者役職名 Chairman of the Board President Chief Executive Officer 取締役会長兼最高経営責任者(CEO)
電話番号 +1 513-579-9911
設立年月日 41671
市場名 NASDAQ National Market System
ipoyear 2016年
従業員数 2500人
url www.medpace.com
nasdaq_url https://www.nasdaq.com/symbol/medp
adr_tso
EBITDA EBITDA(百万ドル) 118.75300
終値(lastsale) 57
時価総額(marketcap) 2027575728
時価総額 時価総額(百万ドル) 1865.725
売上高 売上高(百万ドル) 556.54600
企業価値(EV) 企業価値(EV)(百万ドル) 232.587
当期純利益 当期純利益(百万ドル) 49.25000
決算概要 決算概要 BRIEF: For the six months ended 30 June 2018 Medpace Holdings Inc revenues increased 57% to $333.2M. Net income applicable to common stockholders increased 72% to $31M. Revenues reflect an increase in demand for the Company's products and services due to favorable market conditions. Net income benefited from Amortization decrease of 22% to $14.8M (expense) Miscellaneous (expense) income net increase from $497K (expense) to $325K (income).

 MEDPのテクニカル分析


 MEDPのニュース

   Impact Of Covid-19 On Central Lab Market Demand and Future Scope With Top Key Players- Medpace Reference Laboratory, PPD Central Lab and Q² Solutions and Others  2021/02/23 21:33:59 OpenPR
Impact of COVID-19 on the Healthcare Industry The COVID-19 pandemic has caused severe impacts on the global economy at various levels and which can be seen on the Healthcare industry as well. The thriving market of health care research and development
   Medpace Holdings, Inc. Reports Fourth Quarter and Full Year 2020 Results  2021/02/15 21:15:00 Business Wire
CINCINNATI--(BUSINESS WIRE)--Medpace Holdings, Inc. (Nasdaq: MEDP) (“Medpace”) today announced financial results for the fourth quarter and full year ended December 31, 2020. Fourth Quarter and Full Year 2020 Financial Results Revenue for the three months ended December 31, 2020 increased 13.0% to $259.7 million, compared to $229.9 million for the comparable prior-year period. Revenue for the year ended December 31, 2020 increased 7.5% to $925.9 million, compared to $861.0 million for the year
   Insider Selling: Medpace Holdings, Inc. (NASDAQ:MEDP) General Counsel Sells $1,554,800.00 in Stock  2021/02/14 09:24:41 Watchlist News
Medpace Holdings, Inc. (NASDAQ:MEDP) General Counsel Stephen P. Ewald sold 10,000 shares of the firm’s stock in a transaction on Tuesday, February 9th. The stock was sold at an average price of $155.48, for a total value of $1,554,800.00. Following the transaction, the general counsel now owns 23,854 shares in the company, valued at $3,708,819.92. […]
   The Daily Biotech Pulse: European Regulatory Nod For Xeris, Amicus Falls On Data, 4 IPOs, FDA Decision For Mallinckrodt's StrataGraft Delayed  2021/02/12 13:10:51 Benzinga
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Feb. 12) 4D Molecular Therapeutics Inc (NASDAQ: FDMT ) Adagene Inc (NASDAQ: ADAG ) (went public Tuesday) Agios Pharmaceuticals Inc (NASDAQ: AGIO ) AnaptysBio Inc (NASDAQ: ANAB ) (received a double upgrade from JPMorgan) AngioDynamics, Inc. (NASDAQ: ANGO ) Applied Molecular Transport Inc. (NASDAQ: AMTI ) argenx SE – ADR (NASDAQ: ARGX ) Atea Pharmaceuticals Inc (NASDAQ: AVIR ) AtriCure Inc. (NASDAQ: ATRC ) Ayala Pharmaceuticals Inc (NASDAQ: AYLA ) Bausch Health Companies Inc (NYSE: BHC ) Bolt Biotherapeutics Inc (NASDAQ: BOLT ) C4 Therapeutics Inc (NASDAQ: CCCC ) Cara Therapeutics Inc (NASDAQ: CARA ) Celcuity Inc (NASDAQ: CELC ) Checkpoint Therapeutics Inc (NASDAQ: CKPT ) Collplant Biotechnologies Ltd – ADR (NASDAQ: CLGN ) DermTech Inc (NASDAQ: DMTK ) ( announced award of contract for coverage of its skin cancer gene expression test) ESSA Pharma Inc (NASDAQ: EPIX ) (reacted to first-quarter results) Evogene Ltd (NASDAQ: EVGN ) FibroGen Inc (NASDAQ: FGEN ) G1 Therapeutics Inc (NASDAQ: GTHX ) Genetron Holdings Ltd – ADR (NASDAQ: GTH ) GenMark Diagnostics, Inc (NASDAQ: GNMK ) (moved on M&A speculation) Guardant Health Inc (NASDAQ: GH ) Guardion Health Sciences Inc (NASDAQ: GHSI ) Horizon Therapeutics PLC (NASDAQ: HZNP ) Immunome Inc (NASDAQ: IMNM ) Infinity Pharmaceuticals Inc.
   The Daily Biotech Pulse: DermTech Soars On Contract, Fluidigm Plunges On Earnings, Decision Day For Regeneron, Bioventus Debuts  2021/02/11 12:26:22 Benzinga
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Feb. 11) 10X Genomics Inc (NASDAQ: TXG ) 9 Meters Biopharma Inc (NASDAQ: NMTR ) Abbott Laboratories (NYSE: ABT ) Acasti Pharma Inc (NASDAQ: ACST ) (reacted to its quarterly results) Advaxis, Inc. (NASDAQ: ADXS ) Agios Pharmaceuticals Inc (NASDAQ: AGIO ) Alimera Sciences Inc (NASDAQ: ALIM ) Alkermes Plc (NASDAQ: ALKS ) Allakos Inc (NASDAQ: ALLK ) Anchiano Therapeutics Ltd – ADR (NASDAQ: ANCN AngioDynamics, Inc. (NASDAQ: ANGO ) Applied Molecular Transport Inc. (NASDAQ: AMTI ) Apyx Medical Corp (NASDAQ: APYX ) Arrowhead Pharmaceuticals Inc (NASDAQ: ARWR ) Artelo Biosciences Inc (NASDAQ: ARTL ) Aslan Pharmaceuticals Ltd (NASDAQ: ASLN ) AtriCure Inc. (NASDAQ: ATRC ) Avanos Medical Inc (NYSE: AVNS ) Beigene Ltd (NASDAQ: BGNE ) Bio-Path Holdings Inc (NASDAQ: BPTH ) (announced receipt of third patent related to manufacture of platform technology) Bolt Biotherapeutics Inc (NASDAQ: BOLT ) C4 Therapeutics Inc (NASDAQ: CCCC ) Cancer Genetics Inc (NASDAQ: CGIX ) (reacted to an update to merger terms with StemoniX) Cara Therapeutics Inc (NASDAQ: CARA ) Celcuity Inc (NASDAQ: CELC ) Cellular Biomedicine Group Inc (NASDAQ: CBMG ) Clearpoint Neuro Inc (NASDAQ: CLPT ) Clearside Biomedical Inc (NASDAQ: CLSD ) Collegium Pharmaceutical Inc (NASDAQ: COLL ) Collplant Biotechnologies Ltd – ADR (NASDAQ: CLGN ) Edap Tms SA (NASDAQ: EDAP ) Evogene Ltd (NASDAQ: EVGN ) Eyenovia Inc (NASDAQ: EYEN ) G1 Therapeutics Inc (NASDAQ: GTHX ) Gamida Cell Ltd (NASDAQ: GMDA ) ( reacted to a positive late-stags readout) Genetron Holdings Ltd – ADR (NASDAQ: GTH ) Glaukos Corp (NYSE: GKOS ) Guardion Health Sciences Inc (NASDAQ: GHSI ) Ideaya Biosciences Inc (NASDAQ: IDYA ) Illumina, Inc.
   Contract Research Organization Market to Witness Huge Growth by 2024| Key Players are IQVIA Holdings, Inc., Laboratory Corporation of America Holdings, Syneos Health Inc, PRA Health Sciences, Medpace Holdings Inc and Wuxi AppTec Co Ltd  2021/01/11 14:21:10 OpenPR
ReportsnReports.com the exclusive leading provider of market research reports published research report on “China Contract Research Organization (CRO) Market (Clinical, Pre-clinical & Discovery): Insights, Trends and Forecast (2020-2024)”. China CRO market value is anticipated to reach US$27.04 billion in 2024, growing
   Insider Selling: Medpace Holdings, Inc. (NASDAQ:MEDP) CEO Sells 185,219 Shares of Stock  2021/01/09 04:22:41 Watchlist News
Medpace Holdings, Inc. (NASDAQ:MEDP) CEO August J. Troendle sold 185,219 shares of the firm’s stock in a transaction dated Thursday, January 7th. The shares were sold at an average price of $140.06, for a total transaction of $25,941,773.14. NASDAQ:MEDP traded up $1.86 during midday trading on Friday, hitting $141.76. 184,940 shares of the stock were […]
   Medpace Holdings, Inc. to Report Fourth Quarter and Fiscal Year 2020 Financial Results on February 15, 2021  2021/01/05 21:05:00 Business Wire
CINCINNATI--(BUSINESS WIRE)--Medpace Holdings, Inc. (Nasdaq: MEDP) (“Medpace”) today announced that it will report its fourth quarter and fiscal year 2020 financial results after the market close on Monday, February 15, 2021. The Company will host a conference call the following morning, Tuesday, February 16, 2021, at 9:00 a.m. ET to discuss these results. To participate in the conference call, dial 800-219-7113 (domestic) or 574-990-1030 (international) using the passcode 9646903. To access th
   Insider Selling: Medpace Holdings, Inc. (NASDAQ:MEDP) CEO Sells $496,970.17 in Stock  2021/01/01 10:22:41 Watchlist News
Medpace Holdings, Inc. (NASDAQ:MEDP) CEO August J. Troendle sold 3,547 shares of the firm’s stock in a transaction on Wednesday, December 23rd. The shares were sold at an average price of $140.11, for a total transaction of $496,970.17. Following the completion of the sale, the chief executive officer now owns 706,643 shares in the company, […]
   Insider Selling: Medpace Holdings, Inc. (NASDAQ:MEDP) General Counsel Sells 10,000 Shares of Stock  2020/12/15 10:04:43 Watchlist News
Medpace Holdings, Inc. (NASDAQ:MEDP) General Counsel Stephen P. Ewald sold 10,000 shares of the company’s stock in a transaction on Thursday, December 10th. The shares were sold at an average price of $140.07, for a total transaction of $1,400,700.00. Following the completion of the sale, the general counsel now directly owns 23,854 shares in the […]
   Medpace Holdings, Inc. to Present at the Credit Suisse Healthcare Conference  2020/10/29 20:05:00 Business Wire
CINCINNATI--(BUSINESS WIRE)--Medpace Holdings, Inc. (Nasdaq: MEDP) (“Medpace”) today announced that it will present at the following investor conference: Credit Suisse Healthcare Conference Date: Tuesday, November 10, 2020 Presentation: 9:30 a.m. ET Speakers: August Troendle, President & Chief Executive Officer, Jesse Geiger, Chief Financial Officer & Chief Operating Officer, Laboratory Operations, and Kevin Brady, Executive Director of Finance A live webcast of the presentation will be
   Medpace Holdings, Inc. Reports Third Quarter 2020 Results  2020/10/26 20:15:00 Business Wire
CINCINNATI--(BUSINESS WIRE)--Medpace Holdings, Inc. (Nasdaq: MEDP) (“Medpace”) today announced financial results for the third quarter ended September 30, 2020. Third Quarter 2020 Financial Results Revenue for the three months ended September 30, 2020 increased 6.5% to $230.4 million, compared to $216.2 million for the comparable prior-year period. On a constant currency organic basis, revenue for the third quarter of 2020 increased 5.8% compared to the third quarter of 2019. Backlog as of Sept
   Medpace (NASDAQ:MEDP) Rating Lowered to Buy at BidaskClub  2020/10/24 06:12:52 Dispatch Tribunal
Medpace (NASDAQ:MEDP) was downgraded by equities researchers at BidaskClub from a “strong-buy” rating to a “buy” rating in a research note issued to investors on Thursday, BidAskClub reports. A number of other equities research analysts also recently commented on the stock. SunTrust Banks lifted their price target on shares of Medpace from $95.00 to $124.00 […]
   TSLA Tumbles After S&P 500 Shun  2020/09/04 21:27:42 Zero Hedge
TSLA Tumbles After S&P 500 Shun Tyler Durden Fri, 09/04/2020 - 17:27 But, but, but… everyone was so certain!! S&P Dow Jones Indices have just issued a statement confirming new additions and deletions from their major indices. S&P Dow Jones Indices will make the following index adjustments to the S&P 500, S&P MidCap 400 and S&P SmallCap 600 to ensure each index more appropriately represents its market capitalization range. The changes will be effective prior to the open of trading on Monday, September 21, 2020 to coincide with the September quarterly rebalance: S&P MidCap 400 constituents Etsy Inc. (NASD:ETSY), Teradyne Inc. (NASD:TER), and Catalent Inc. (NYSE:CTLT) will move to the S&P 500 , replacing H&R Block Inc. (NYSE:HRB) Coty Inc. (NYSE:COTY) and Kohl's Corp. (NYSE:KSS), all of which will move to the S&P MidCap 400. S&P SmallCap 600 constituents Wingstop Inc. (NASD:WING), Medpace Holdings Inc. (NASD:MEDP), and Fox Factory Holding Corp. (NASD:FOXF) will move to the S&P MidCap 400, replacing PBF Energy Inc. (NYSE:PBF), Allegheny Technologies Inc. (NYSE:ATI) and Mack-Cali Realty Corp. (NYSE:CLI), all of which will move to the S&P SmallCap 600.
   Medpace Holdings, Inc. to Report Third Quarter 2020 Financial Results on October 26, 2020  2020/09/02 20:05:00 Business Wire
CINCINNATI--(BUSINESS WIRE)--Medpace Holdings, Inc. (Nasdaq: MEDP) (“Medpace”) today announced that it will report its third quarter 2020 financial results after the market close on Monday, October 26, 2020. The Company will host a conference call the following morning, Tuesday, October 27, 2020, at 9:00 a.m. ET to discuss these results. To participate in the conference call, dial 800-219-7113 (domestic) or 574-990-1030 (international) using the passcode 6989449. To access the conference call v

 関連キーワード  (バイオテクノロジ―_メディカルリサ―チ 米国株 メッドペ―ス・ホ―ルディングス MEDP Medpace Holdings Inc.)

 twitter  (公式ツイッターやCEOツイッターなど)